A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 16419081)

Published in Hum Mutat on March 01, 2006

Authors

A Osorio1, B Martínez-Delgado, M Pollán, M Cuadros, M Urioste, C Torrenteras, L Melchor, O Díez, M De La Hoya, E Velasco, R González-Sarmiento, T Caldés, C Alonso, J Benítez

Author Affiliations

1: Department of Human Genetics, Spanish National Cancer Center, Madrid, Spain. aosorio@cnio.es

Articles citing this

Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer (2008) 1.08

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil. BMC Cancer (2008) 1.02

WDR36 and P53 gene variants and susceptibility to primary open-angle glaucoma: analysis of gene-gene interactions. Invest Ophthalmol Vis Sci (2011) 0.91

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Br J Cancer (2009) 0.90

Single Nucleotide Polymorphisms in Selected Apoptotic Genes and BPDE-Induced Apoptotic Capacity in Apparently Normal Primary Lymphocytes: A Genotype-Phenotype Correlation Analysis. J Cancer Epidemiol (2008) 0.84

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Br J Cancer (2009) 0.82

Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent. BMC Cancer (2008) 0.81

Mutation analysis of the MDM4 gene in German breast cancer patients. BMC Cancer (2008) 0.79

An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. Br J Cancer (2008) 0.79

Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Fam Cancer (2008) 0.78

Germline TP53 mutational spectrum in French Canadians with breast cancer. BMC Med Genet (2015) 0.75

Inherited and acquired alterations in development of breast cancer. Appl Clin Genet (2011) 0.75

Articles by these authors

New acrofacial dysostosis syndrome in 3 sibs. Am J Med Genet (1990) 2.63

Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol (2001) 2.56

Complications of hysteroscopic Essure(®) sterilisation: report on 4306 procedures performed in a single centre. BJOG (2012) 2.16

Systematic review with meta-analysis: the I148M variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis. Aliment Pharmacol Ther (2014) 2.11

Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem (2003) 1.81

A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J (2000) 1.78

Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. Cancer Genet Cytogenet (2003) 1.70

Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ (2001) 1.69

Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev (2000) 1.68

Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics. Blood (1991) 1.64

SLC45A2: a novel malignant melanoma-associated gene. Hum Mutat (2008) 1.50

Acute lymphoid leukemias following either a previous chronic myelogenous leukemia or myelodysplastic syndrome: phenotypic and genomic differences. Am J Hematol (1993) 1.48

A head-to-tail tandem organization of hsp70 genes in Trypanosoma cruzi. Nucleic Acids Res (1988) 1.47

Novel tetranuclear orthometalated complexes of Pd(II) and Pt(II) derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cell lines. Interaction of these complexes with DNA. J Med Chem (1998) 1.47

The 12 base pair duplication/insertion alteration could be a regulatory mutation. J Med Genet (1997) 1.44

Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. J Nucl Med (1990) 1.43

Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med (1990) 1.42

Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia. Haematologica (2001) 1.41

[Analysis of the HFE gene in a large Spanish kindred with hereditary hemochromatosis]. Med Clin (Barc) (2001) 1.39

[Prevalence of Factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes]. Sangre (Barc) (1999) 1.39

Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study. Pacing Clin Electrophysiol (2003) 1.38

Characterization of a non-long terminal repeat retrotransposon cDNA (L1Tc) from Trypanosoma cruzi: homology of the first ORF with the ape family of DNA repair enzymes. J Mol Biol (1995) 1.36

The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat (2001) 1.36

Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information. Hum Mutat (2007) 1.33

3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res (1998) 1.31

Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model. Vet Immunol Immunopathol (2000) 1.29

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. Pharmacogenomics J (2009) 1.28

Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes. Oncogene (2007) 1.28

Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment. Breast Cancer Res Treat (2009) 1.25

X-linked ichthyosis: an update. Br J Dermatol (1999) 1.25

The molecular pathology of hereditary breast cancer. Pathobiology (2008) 1.25

Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol Today (2000) 1.21

BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol (2011) 1.20

Analysis of post-transcriptional regulation operating on transcription products of the tandemly linked Leishmania infantum hsp70 genes. J Biol Chem (1997) 1.19

Municipal pleural cancer mortality in Spain. Occup Environ Med (2005) 1.18

MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer. Clin Genet (2007) 1.17

Do non-long terminal repeat retrotransposons have nuclease activity? Trends Biochem Sci (1996) 1.17

Additional complexity on human chromosome 15q: identification of a set of newly recognized duplicons (LCR15) on 15q11-q13, 15q24, and 15q26. Genome Res (2001) 1.17

The role of charged amphipathic helices in the structure and function of surfactant protein B. J Pept Res (2005) 1.16

Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population. Clin Pharmacol Ther (1995) 1.15

Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer. Breast Cancer Res Treat (2011) 1.15

Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia (2005) 1.14

Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J Proteome Res (2012) 1.14

Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis. J Clin Microbiol (1998) 1.13

Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach. Leukemia (2006) 1.13

Langevin computer simulations of bacterial protein filaments and the force-generating mechanism during cell division. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 1.12

Acute health problems among subjects involved in the cleanup operation following the Prestige oil spill in Asturias and Cantabria (Spain). Environ Res (2005) 1.12

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12

The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response. Virology (1998) 1.11

African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death. Virology (1996) 1.10

Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization. J Virol (1996) 1.10

Lhermitte-Duclos disease and Cowden disease: clinical and genetic study in five patients with Lhermitte-Duclos disease and literature review. Acta Neurochir (Wien) (2004) 1.10

An unusual variant of chromosome 16. Two new cases. Hum Genet (1988) 1.09

Genomic organization and expression of two independent gene arrays coding for two antigenic acidic ribosomal proteins of Leishmania. J Biol Chem (1993) 1.08

In situ hybridization of nuclear and cytoplasmic RNA to locus 2-48BC in Drosophila hydei. Chromosoma (1978) 1.08

Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas. Leukemia (2001) 1.08

Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83. Mol Immunol (1999) 1.07

Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu/nu BALB/c mice. Infect Immun (1998) 1.06

[Achondroplasia: molecular study of 28 patients]. Med Clin (Barc) (1998) 1.06

Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation. Leukemia (2007) 1.06

Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae. J Clin Microbiol (2006) 1.06

Characterization and molecular basis of heterogeneity of the African swine fever virus envelope protein p54. J Virol (1994) 1.06

MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population. Carcinogenesis (2007) 1.06

Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. Biochim Biophys Acta (1999) 1.06

Homozygous tandem duplication within the gene encoding the beta-subunit of rod phosphodiesterase as a cause for autosomal recessive retinitis pigmentosa. Hum Mutat (1995) 1.05

Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism. FEBS Lett (1999) 1.04

How to exploit twitter for public health monitoring? Methods Inf Med (2013) 1.04

Z-DNA in transcriptionally active chromosomes. Proc Natl Acad Sci U S A (1987) 1.03

Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol (2005) 1.03

Lipogenesis in vivo in maternal and foetal tissues during late gestation in the rat. Biochem J (1981) 1.03

Binuclear chloro-bridged palladated and platinated complexes derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxicity against cisplatin resistant tumor cell lines. J Inorg Biochem (1998) 1.03

Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study. Int J Cancer (2006) 1.02

Evidence against involvement of recoverin in autosomal recessive retinitis pigmentosa in 42 Spanish families. Hum Genet (1995) 1.02

Identification of a putative regulatory element in the 3'-untranslated region that controls expression of HSP70 in Leishmania infantum. Mol Biochem Parasitol (2000) 1.02

DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect Immun (2001) 1.02

Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression. Am J Pathol (1998) 1.01

The open reading frame 1 of the L1Tc retrotransposon of Trypanosoma cruzi codes for a protein with apurinic-apyrimidinic nuclease activity. J Biol Chem (1997) 1.01

Characterization of Le(x), Le(y) and A Le(y) antigen determinants in KDN-containing O-linked glycan chains from Pleurodeles waltlii jelly coat eggs. FEBS Lett (1992) 1.00

Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunol Lett (1995) 1.00

Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers. Pharmacogenetics (1996) 1.00

Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunol (2006) 1.00

Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets. Crit Rev Oncol Hematol (2008) 0.99

Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6. Acta Psychiatr Scand (1993) 0.99

Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients. Ann Oncol (2011) 0.99

[The Pro347Leu mutation of the rhodopsin gene in a Spanish family with autosomal dominant pigmentary retinosis]. Med Clin (Barc) (1998) 0.99

Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists. Clin Pharmacol Ther (1999) 0.99

Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect (2013) 0.99

Locations of Z-DNA in polytene chromosomes. J Cell Biol (1985) 0.98

X-linked ichthyosis along with recessive dystrophic epidermolysis bullosa in the same patient. Dermatology (2010) 0.98

Antibiotics for the common cold: expectations of Germany's general population. Euro Surveill (2010) 0.98

Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br J Cancer (2000) 0.98

The location of 5S (ribosomal) RNA genes in Drosophila hydei. Chromosoma (1975) 0.98

Stomach cancer and occupation in Sweden: 1971-89. Occup Environ Med (2002) 0.97

Leishmania: fine mapping of the Leishmanolysin molecule's conserved core domains involved in binding and internalization. Exp Parasitol (1999) 0.97